动菌体:抗癌代谢物的来源
Muralidharan Kabilan1, Veeramuthu Duraipandiyan1, Prince Paul1
1Division of Microbiology, Entomology Research Institute, Loyola College, Chennai-600034, Tamil Nadu, India.
Current medicinal chemistry
|December 24, 2024
概括
细菌Actinomycetes可以产生抗癌化合物. 本综述总结了2000年至2022年期间发现的海洋和土壤actinomycete衍生的抗癌剂,突出了它们在癌症治疗开发中的潜力.
科学领域:
- 微生物学 微生物学
- 药理学 药理学是指药理学的学科.
- 自然产品 化学 化学
背景情况:
- 动态菌体 (Actinomycetes) 是一种产生多种生物活性化合物,包括临床重要抗生素的グラム阳性细菌.
- 这些在陆地和海洋环境中发现的微生物是新型治疗剂的丰富来源.
- 癌症仍然是一个重大的全球健康挑战,对有效治疗的需求尚未得到满足.
研究的目的:
- 审查和巩固从各种actinomycetes中分离出来的抗癌和细胞毒性化合物.
- 突出了由actinomycete衍生的化合物作为新型化疗剂的潜力.
- 为了鼓励进一步的研究,在癌症药物发现的行为菌体.
主要方法:
- 2000-2022年科学出版物的文献综述.
- 鉴定和总结来自海洋和土壤actinomycetes的抗癌和细胞毒性化合物.
- 报告的隔离源和化合物活动的分析.
主要成果:
- 许多抗癌和细胞毒性化合物已经从各种类型的菌虫中分离出来.
- 这些化合物表现出与癌症治疗相关的一系列生物活性.
- 在2000年至2022年期间,从actinomycetes中发现了新的抗癌剂.
结论:
- 动菌体是发现新抗癌药物的有希望的来源.
- 继续探索状菌体,特别是来自海洋环境的菌体,对于推进癌症治疗至关重要.
- 需要进一步的研究来开发这些化合物成为可行的化疗剂.
相关概念视频
Drugs that Stabilize Microtubules
1.9K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
1.9K
Drugs that Destabilize Microtubules
1.9K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
1.9K
The Citric Acid Cycle
149.7K
The citric acid cycle, also known as the Krebs cycle or TCA cycle, consists of several energy-generating reactions that yield one ATP molecule, three NADH molecules, one FADH2 molecule, and two CO2 molecules.
149.7K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Adaptive Mechanisms in Cancer Cells
5.5K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.5K
Electron Transport Chain: Complex I and II
9.5K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
9.5K


